Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

IOVA
Iovance Biotherapeutics, Inc.US flagNASDAQ Global Market
4.35
USD
+0.16
- -
1.56BMarket Cap

Iovance Biotherapeutics, Inc. (IOVA) Stock Split History

Learn about Iovance Biotherapeutics, Inc.'s most recent 1-for-100 basis stock split on September 26, 2013. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Iovance Biotherapeutics, Inc.'s most recent stock split

Split Date: 2013-09-26
Split Ratio: 1:100
Price Before Split: $0.04
Price After Split: $0.00

Developer API

Get IOVA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/IOVA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 100.00 times fewer shares (a 1:100 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Iovance Biotherapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2013-09-261:100Yes$0.04$0.00
2010-05-2623999:1000NoN/AN/A

About Iovance Biotherapeutics, Inc.

Company overview and industry information

Iovance Biotherapeutics, Inc. (IOVA) operates in the Biotechnology industry. The recent 1-for-100 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Iovance Biotherapeutics, Inc. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.